Background: Antipsychotic medications are conventionally divided into two groups: First-
generation and second-generation antipsychotics (FGAs and SGAs). There is a …

This review covers studies wherein therapeutic effects and adverse events of these drugs in
schizophrenia patients were compared in head-to-head studies and that were published in …

Introduction Antipsychotic medications are mainstays in the treatment of schizophrenia and
a range of other psychotic disorders. Sources of data Recent meta-analyses of antipsychotic …

Objective: To comprehensively review the 2 recent and large antipsychotic effectiveness
trials for treatment of schizophrenia: the United Kingdom's Cost Utility of the Latest …

Schizophrenia is characterized by positive, negative, cognitive, disorganization, and mood
symptoms. Antipsychotics are the mainstay in the pharmacologic treatment of schizophrenia …

Over the course of the past decade, the acceptance of several second-generation
antipsychotics (SGAs) as effective medication for the treatment of schizophrenia has led to …

Data from two major government-funded studies of comparative antipsychotic effectiveness
in schizophrenia contradict the widely prevalent belief that the newer second-generation …

Schizophrenia is a severe progressive and debilitating condition, comprised of three primary
symptom domains: positive, negative, and cognitive. Individuals with schizophrenia have a …

Background: Debate continues about the comparative benefits and harms of first-generation
antipsychotics (FGAs) and second-generation antipsychotics (SGAs) in treating …

Background The question of which antipsychotic drug should be preferred for the treatment
of schizophrenia is controversial, and conventional pairwise meta-analyses cannot provide …